Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

Me, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. 23andMe said Monday it will lay off ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...

A company representative shows off what is in a DNA kit at the 23andMe booth at the RootsTech annual genealogical event in ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

Springfield-based MassMutual says its CFO is retiring at the end of the year after 30 years with the insurance giant, and ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

Andme Holding Co ( (ME) ) has released its Q2 earnings. Here is a breakdown of the information 23Andme Holding Co presented to its investors.

Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe Holding ...